Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model

Per- and polyfluoroalkyl substances (PFAS) are a large group of synthetic surfactants of over 12,000 compounds that are incorporated into numerous products for their chemical and physical properties. Studies have associated PFAS with adverse health effects. Although there is a high potential for der...

Full description

Saved in:
Bibliographic Details
Main Authors: Lisa M. Weatherly, Hillary L. Shane, Laurel G. Jackson, Ewa Lukomska, Rachel Baur, Madison P. Cooper, Stacey E. Anderson
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Immunotoxicology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/1547691X.2024.2371868
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841525437142925312
author Lisa M. Weatherly
Hillary L. Shane
Laurel G. Jackson
Ewa Lukomska
Rachel Baur
Madison P. Cooper
Stacey E. Anderson
author_facet Lisa M. Weatherly
Hillary L. Shane
Laurel G. Jackson
Ewa Lukomska
Rachel Baur
Madison P. Cooper
Stacey E. Anderson
author_sort Lisa M. Weatherly
collection DOAJ
description Per- and polyfluoroalkyl substances (PFAS) are a large group of synthetic surfactants of over 12,000 compounds that are incorporated into numerous products for their chemical and physical properties. Studies have associated PFAS with adverse health effects. Although there is a high potential for dermal exposure, these studies are lacking. The present study evaluated the systemic and immunotoxicity of subchronic 28- or 10-days of dermal exposure, respectively, to PFHpS (0.3125–2.5% or 7.82–62.5 mg/kg/dose) or PFOS (0.5% or 12.5 mg/kg/dose) in a murine model. Elevated levels of PFHpS were detected in the serum and urine, suggesting that absorption is occurring through the dermal route. PFHpS induced significantly increased relative liver weight, significantly decreased relative spleen and thymus weight, altered serum chemistries, and altered histopathology. Additionally, PFHpS significantly reduced the humoral immune response and altered immune subsets in the spleen, suggesting immunosuppression. Gene expression changes were observed in the liver, skin, and spleen of genes involved in fatty acid metabolism, necrosis, and inflammation. Immune-cell phenotyping identified significant decreases in B-cells and CD11b+ monocyte and/or macrophages in the spleen along with decreases in eosinophils and dendritic cells in the skin. These findings support PFHpS absorption through the skin leading to liver damage and immune suppression.
format Article
id doaj-art-1ffc478bf3e048dfa164729885b8c714
institution Kabale University
issn 1547-691X
1547-6901
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Immunotoxicology
spelling doaj-art-1ffc478bf3e048dfa164729885b8c7142025-01-17T12:52:14ZengTaylor & Francis GroupJournal of Immunotoxicology1547-691X1547-69012024-12-0121110.1080/1547691X.2024.2371868Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine modelLisa M. Weatherly0Hillary L. Shane1Laurel G. Jackson2Ewa Lukomska3Rachel Baur4Madison P. Cooper5Stacey E. Anderson6Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USAAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USAAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USAAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USAAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USAAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USAAllergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USAPer- and polyfluoroalkyl substances (PFAS) are a large group of synthetic surfactants of over 12,000 compounds that are incorporated into numerous products for their chemical and physical properties. Studies have associated PFAS with adverse health effects. Although there is a high potential for dermal exposure, these studies are lacking. The present study evaluated the systemic and immunotoxicity of subchronic 28- or 10-days of dermal exposure, respectively, to PFHpS (0.3125–2.5% or 7.82–62.5 mg/kg/dose) or PFOS (0.5% or 12.5 mg/kg/dose) in a murine model. Elevated levels of PFHpS were detected in the serum and urine, suggesting that absorption is occurring through the dermal route. PFHpS induced significantly increased relative liver weight, significantly decreased relative spleen and thymus weight, altered serum chemistries, and altered histopathology. Additionally, PFHpS significantly reduced the humoral immune response and altered immune subsets in the spleen, suggesting immunosuppression. Gene expression changes were observed in the liver, skin, and spleen of genes involved in fatty acid metabolism, necrosis, and inflammation. Immune-cell phenotyping identified significant decreases in B-cells and CD11b+ monocyte and/or macrophages in the spleen along with decreases in eosinophils and dendritic cells in the skin. These findings support PFHpS absorption through the skin leading to liver damage and immune suppression.https://www.tandfonline.com/doi/10.1080/1547691X.2024.2371868Perfluoroheptane sulfonic acid (PFHpS;), toxicityimmunedermalliver damagePPARimmunosuppression
spellingShingle Lisa M. Weatherly
Hillary L. Shane
Laurel G. Jackson
Ewa Lukomska
Rachel Baur
Madison P. Cooper
Stacey E. Anderson
Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model
Journal of Immunotoxicology
Perfluoroheptane sulfonic acid (PFHpS;), toxicity
immune
dermal
liver damage
PPAR
immunosuppression
title Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model
title_full Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model
title_fullStr Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model
title_full_unstemmed Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model
title_short Systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid (PFHpS) or perfluorooctane sulfonic acid (PFOS) in a murine model
title_sort systemic and immunotoxicity induced by topical application of perfluoroheptane sulfonic acid pfhps or perfluorooctane sulfonic acid pfos in a murine model
topic Perfluoroheptane sulfonic acid (PFHpS;), toxicity
immune
dermal
liver damage
PPAR
immunosuppression
url https://www.tandfonline.com/doi/10.1080/1547691X.2024.2371868
work_keys_str_mv AT lisamweatherly systemicandimmunotoxicityinducedbytopicalapplicationofperfluoroheptanesulfonicacidpfhpsorperfluorooctanesulfonicacidpfosinamurinemodel
AT hillarylshane systemicandimmunotoxicityinducedbytopicalapplicationofperfluoroheptanesulfonicacidpfhpsorperfluorooctanesulfonicacidpfosinamurinemodel
AT laurelgjackson systemicandimmunotoxicityinducedbytopicalapplicationofperfluoroheptanesulfonicacidpfhpsorperfluorooctanesulfonicacidpfosinamurinemodel
AT ewalukomska systemicandimmunotoxicityinducedbytopicalapplicationofperfluoroheptanesulfonicacidpfhpsorperfluorooctanesulfonicacidpfosinamurinemodel
AT rachelbaur systemicandimmunotoxicityinducedbytopicalapplicationofperfluoroheptanesulfonicacidpfhpsorperfluorooctanesulfonicacidpfosinamurinemodel
AT madisonpcooper systemicandimmunotoxicityinducedbytopicalapplicationofperfluoroheptanesulfonicacidpfhpsorperfluorooctanesulfonicacidpfosinamurinemodel
AT staceyeanderson systemicandimmunotoxicityinducedbytopicalapplicationofperfluoroheptanesulfonicacidpfhpsorperfluorooctanesulfonicacidpfosinamurinemodel